Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


The use of bone marrow mononuclears in the treatmentof patients with severe ischemic heart disease

Authors: N.E. Alieva

Company:
Bakoulev National Medical Research Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2019-16-3-165-174

UDC: 616.12-005.4-08:611.018.46:576.5

Link: Clinical Physiology of Blood Circulaiton. 2019; 16 (3): 165-174

Quote as: Alieva N.E. The use of bone marrow mononuclears in the treatment of patients with severe ischemic heart disease. Clinical Physiology of Circulation. 2019; 16 (3): 165–74 (in Russ.). DOI: 10.24022/1814-6910-2019-16-3-165-174

Received / Accepted:  02.04.2019/12.08.2019

Download
Full text:  

Abstract

The low ability of a myocardium to regeneration at adults considerably limits its recovery abilities in case of ischemia and leads to development of complications in the form of development of postinfarction aneurysms, an ischemic cardiomyopathy with decrease in fraction of emission, and in the subsequent to heart failure. Use of cellular technologies together with surgical methods of treatment and conservative therapy, can replace the damaged sites of a myocardium with the living functioning cells. However active introduction of cellular technologies into experimental and practical medicine leads to the emergence of a number of questions: how efficiently did cell transplantation take, how many cells are transplanted and their “descendants” in the recipient's body, what is the localization of cells in the tissues, how has differentiation gone. To assess the engraftment of mesenchymal stem cells in the recipient's body, it is necessary to monitor the cells after their transplantation.

This review describes the morphology of the structure of the myocardium, the cytological mechanisms of myocardial damage in coronary artery disease, also presents methods for labeling cells to identify the most effective methods of administration.

About Authors

Nailya E. Alieva, Postgraduate; orcid.org/0000-0003-0283-0545

 If you found mistakes, select text and press Alt+A